Lymphocyte recovery after fingolimod discontinuation in patients with MS
Conclusions
Prolonged lymphopenia after fingolimod cessation exists in a subgroup of patients with MS and should be considered in clinical practice, particularly when changing treatment regimens.
Source: Neurology Neuroimmunology and Neuroinflammation - Category: Neurology Authors: Nagy, S., Kuhle, J., Derfuss, T. Tags: All Clinical Neurology, All Demyelinating disease (CNS), Multiple sclerosis Article Source Type: research
More News: Brain | Corticosteroid Therapy | Disability | Gilenya | Multiple Sclerosis | Neurology | Rituxan